Physician profile
Lora J Brown
NPI 1770634701
$4,431.18
in general payments reported to CMS, 2019-2025
37 companies · $29.13 in 2025
The $29.13 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,038 · 2020: $187 · 2021: $764 · 2022: $1,178 · 2023: $1,235 · 2025: $29.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231 · Education: $32.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.19 |
| Education | $32.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.34 | 2019-2023 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $491.49 | 2019-2023 | Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $458.43 | 2019-2023 | Dificid, Steglatro, Belsomra |
| Novo Nordisk INC | $419.40 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $253.56 | 2019-2023 | |
| Glaxosmithkline, LLC. | $210.35 | 2019-2023 | Arexvy, Shingrix |
| Lilly USA, LLC | $189.43 | 2019-2023 | Jardiance, Emgality |
| Abbott Laboratories | $181.66 | 2021-2023 | Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $159.73 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $141.85 | 2022 | |
| Pfizer INC. | $124.98 | 2019-2023 | |
| Exact Sciences Corporation | $123.22 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $122.72 | 2019-2023 | Trintellix |
| Amgen INC. | $102.01 | 2019-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $87.55 | 2022-2023 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.